Skip to main content

Methotrexate Provides Significant Cost Savings for the Treatment of Unruptured Ectopic Pregnancy

Clinical Drug Investigation volume 15, pages 405–411 (1998)Cite this article

Summary

The aim of this study was to compare direct and indirect costs of single-dose methotrexate and laparoscopy in the treatment of unruptured ectopic pregnancy. We conducted a prospective study between 1 January 1995 and 31 May 1997 and recorded costs accrued from outpatient and inpatient treatment with methotrexate (group I) and laparoscopy (group II). We used the French National Social Security nomenclature as reference for the different costs. Indirect costs were estimated from national demographic data. 39 patients were included in group I and 38 in group II. Single-dose methotrexate was the most economic management of unruptured tubal pregnancy ($US1436 per case vs $US3170 per case for laparoscopy) since it reduced the total cost by approximately 50%. This was due to a dramatic reduction in charges related to hospitalisation and the operating room. Indirect costs were also reduced, mainly as a result of a shorter recovery time ($US237 vs $US475). However, there was no further evidence of any cost effectiveness of methotrexate therapy when hospitalisation was required.

In conclusion, single-dose methotrexate appeared to be the most economic approach for the treatment of unruptured ectopic pregnancy. Selection of cases is mandatory to guarantee a cost savings for the treatment of unruptured ectopic pregnancy.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

49,54 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Coste J, Job-Spira N, Aublet-Cuvelier B, et al. Incidence of ectopic pregnancy. First results of a population-based register in France. Hum Reprod 1994; 9: 742–5

    PubMed  CAS  Google Scholar 

  2. Pouly JL, Mahnes H, Mage G, et al. Conservative laparoscopic treatment of 321 ectopic pregnancies. Fertil Steril 1986; 46(6): 1093–7

    PubMed  CAS  Google Scholar 

  3. Azziz R, Steinkampf MP. Postoperative recuperation: relation to the extent of endoscopy surgery. Fertil Steril 1989; 51(6): 1061–4

    PubMed  CAS  Google Scholar 

  4. Maruri F, Azziz R. Laparoscopic surgery for ectopic pregnancies: technology assessment and public health implications. Fertil Steril 1993; 59(3): 487–98

    PubMed  CAS  Google Scholar 

  5. Washington A, Katz P. Ectopic pregnancy in the United States: economic consequences and payment source trends. Obstet Gynecol 1993; 81(2): 287–92

    PubMed  CAS  Google Scholar 

  6. Stovall TG, Ling FW. single-dose methotrexate: an expanded clinical trial. Am J Obstet Gynecol 1933; 168: 1759–65

    Google Scholar 

  7. Lécuru F, Taurelle R, Viens-Bitker C, et al. Cost of unruptured ectopic pregnancy treatment: comparison of laparoscopy and methotrexate injection. Gynaecol Endoscopy 1996; 5: 25–8

    Article  Google Scholar 

  8. Rosen DJ, Ben-Nun I, Arbel Y, et al. Transvaginal ultra-sonographic quantitative assessment of accumulated cul de sac fluid. Am J Obstet Gynecol 1992; 166: 542–4

    PubMed  CAS  Google Scholar 

  9. Girard JP, Lheritier JL. Les salaires en 1990. INSEE Résultats 1992; 34: 62

    Google Scholar 

  10. Desplanques G. Activité féminine et vie familiale. Econ Statist 1993; 261: 23–9

    Article  Google Scholar 

  11. Feichtinger W, Kemeter P. Conservative treatment of ectopic pregnancy by transvaginal aspiration under sonographic control and methotrate injection. Lancet 1987; I: 381–2

    Article  Google Scholar 

  12. Creinin M, Washington A. Cost of ectopic pregnancy management: surgery versus methotrexate. Fertil Steril 1993; 60: 963–9

    PubMed  CAS  Google Scholar 

  13. Yao M, Tulandi T, Kaplow M, et al. A comparison of methotrexate versus laparoscopic surgery for the treatment of ectopic pregnancy: a cost analysis. Hum Reprod 1996; 11: 2762–6

    PubMed  Article  CAS  Google Scholar 

  14. Yao M, Tulandi T. Current status of surgical and non surgical management of ectopic pregnancy. Fertil Steril 1997; 67: 421–3

    PubMed  Article  CAS  Google Scholar 

  15. Hidlebaugh D, O'Mara P. Clinical and financial analysis of ectopic pregnancy management at large health plan. J Am Assoc Gynecol Laparosc 1997; 4: 207–13

    PubMed  Article  CAS  Google Scholar 

  16. Alexander JM, Rouse DJ, Varner E, et al. Treatment of the small unruptured ectopic pregnancy: a cost analysis of methotrexate versus laparoscopy. Obstet Gynecol 1996; 88: 123–7

    PubMed  Article  CAS  Google Scholar 

  17. Lécuru F, Taurelle R, Viens-Bitker C, et al. Cost of unruptured ectopic pregnancy treatment: comparison of laparoscopy and methotrexate injection. Gynaecol Endoscopy 1996; 5: 25–8

    Article  Google Scholar 

  18. Merz E, Bahlman F, Weber G, et al. Unruptured tubal pregnancy: local low dose therapy with methotrexate under transvaginal ultrasonographic guidance. Gynecol Obstet Invest 1996; 41: 76–81

    PubMed  Article  CAS  Google Scholar 

  19. Stika CS, Anderson L, Frederiksen MC. Single dose methotrexate for the treatment of ectopic pregnancy: Northwestern Memorial Hospital three-year experience. Am J Obstet Gynecol 1996; 174: 1840–8

    PubMed  Article  CAS  Google Scholar 

  20. Glock JL, Johnson JV, Brumsted JR. Efficacy and safety of single dose systemic methotrexate in the treatment of ectopic pregnancy. Fertil Steril 1994; 62: 716–21

    PubMed  CAS  Google Scholar 

  21. Lécuru F, Querleu D, Buchet-Bouverne B, et al. The effect of tubal injection of methotrexate on fertility in the rabbit. Fertil Steril 1992; 57: 422–4

    PubMed  Google Scholar 

  22. Fernandez H, Lelaidier C, Baton C, et al. Return of reproductive performance after expectant management and local treatment for ectopic pregnancy. Hum Reprod 1991; 6(10): 1474–7

    PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Service de Gynécologie-Obstétrique, Hôpital Boucicaut, and Faculté de Médecine Necker-Enfants Malades, 78 rue de la Convention, 75015, Paris, France

    François Robin,  Fabrice Lecuru, Jean-Pierre Bernard, Catherine Mac-Cordick, Valérie Boucaya & Roland Tourelle

Authors
  1. François Robin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fabrice Lecuru
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jean-Pierre Bernard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Catherine Mac-Cordick
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Valérie Boucaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Roland Tourelle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fabrice Lecuru.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Robin, F., Lecuru, F., Bernard, JP. et al. Methotrexate Provides Significant Cost Savings for the Treatment of Unruptured Ectopic Pregnancy. Clin. Drug Investig. 15, 405–411 (1998). https://doi.org/10.2165/00044011-199815050-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00044011-199815050-00005

Keywords

  • Methotrexate
  • Adis International Limited
  • Indirect Cost
  • Ectopic Pregnancy
  • Drug Invest